VEXTF Stock Chart & Stats
$0.20
$0.00(0.00%)
At close: 4:00 PM EDT
$0.20
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.10 - $0.32
Previous CloseN/A
Volume50.00
Average Volume (3M)31.16K
Market Cap
$40.96M
Enterprise Value$97.20M
Total Cash (Recent Filing)$4.53M
Total Debt (Recent Filing)$33.71M
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Dec 01, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding185,816,350
10 Day Avg. Volume52,118
30 Day Avg. Volume31,165
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)0.83
Price to Sales (P/S)0.88
P/FCF Ratio5.55
Enterprise Value/Market Cap2.37
Enterprise Value/Revenue1.93
Enterprise Value/Gross Profit10.47
Enterprise Value/Ebitda16.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)$50.33M
Bulls Say, Bears Say
Bulls Say
Improving Margins And EBITDAHigher gross margins and adjusted EBITDA indicate that operating execution is improving despite a difficult revenue environment. If sustained, these gains can strengthen cash conversion, support reinvestment in growth markets, and provide a more durable path toward eventual profitability.
Ohio Growth PlatformOhio is becoming a meaningful growth engine through expanding sales, additional dispensaries, and broader operating scale. Concentrating resources in a market showing stronger demand gives Vext a clearer growth platform and may improve returns as new locations mature.
Cash Generation And Balance-sheet ActionsPositive operating and free cash flow provide internal funding support even while reported earnings remain negative. Combined with refinancing and expansion financing, this gives Vext resources to fund Ohio growth and address debt, although execution will determine how durable the benefit becomes.
Bears Say
Persistent Losses And Declining RevenueThe company has not yet restored consistent bottom-line profitability, while revenue and operating earnings remain under pressure. Persistent losses reduce financial flexibility and make future growth more dependent on successful margin improvement, disciplined spending, and continued access to financing.
Arizona Market WeaknessArizona pricing and demand weakness is forcing Vext to exit cultivation at Eloy because production costs could not compete with market prices. This reduces current revenue and highlights the risk that market deterioration can impair asset economics and disrupt the company’s operating base.
Large Uncertain Tax LiabilityThe enlarged uncertain tax position represents a material claim against near-term financial resources and remains unresolved. Until regulatory changes or other relief reduce the obligation, it can constrain working capital, complicate debt reduction, and limit funds available for Ohio expansion.
Vext Science News
VEXTF FAQ
What was Vext Science’s price range in the past 12 months?
Vext Science lowest stock price was $0.10 and its highest was $0.32 in the past 12 months.
What is Vext Science’s market cap?
Vext Science’s market cap is $40.96M.
When is Vext Science’s upcoming earnings report date?
Vext Science’s upcoming earnings report date is Dec 01, 2026 which is in 53 days.
How were Vext Science’s earnings last quarter?
Vext Science released its earnings results on Aug 20, 2026. The company reported $0 earnings per share for the quarter.
Is Vext Science overvalued?
According to Wall Street analysts Vext Science’s price is currently Overvalued.
Does Vext Science pay dividends?
Vext Science does not currently pay dividends.
What is Vext Science’s EPS estimate?
Vext Science’s EPS estimate is 0.
How many shares outstanding does Vext Science have?
Vext Science has 185,816,350 shares outstanding.
What happened to Vext Science’s price movement after its last earnings report?
Vext Science reported an EPS of $0 in its last earnings report. Following the earnings report the stock price went down -5.023%.
Which hedge fund is a major shareholder of Vext Science?
Currently, no hedge funds are holding shares in VEXTF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vext Science
Vext Science, Inc., through its various subsidiaries, operates as a comprehensive agricultural technology, services, and property management company within the United States cannabis sector. Its operations span the entire product lifecycle, from cultivating and extracting to manufacturing and distributing THC and CBD vape cartridges, concentrates, and edibles. The company also manages retail dispensaries and conducts wholesale distribution of cannabis-derived THC and hemp-derived CBD products, marketed under its Vapen and Pure Touch Botanicals brands. Expanding its edible range, Vext Science offers various THC-infused items under the Vapen Kitchens brand, including Vapen Clear products, chocolate bars, syrups, snacks, candies, and gummies. Incorporated in 2015, the company was formerly known as Vapen MJ Ventures Corporation, adopting its current name, Vext Science, Inc., in November 2019. Its headquarters are located in Phoenix, Arizona.
VEXTF Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized meaningful operational and margin improvements driven by Ohio execution and higher cultivation yields, alongside successful financing and balance sheet progress. These positives were balanced against a lower top line (driven by a planned Arizona cultivation wind-down), ongoing market weakness in Arizona, a significant uncertain tax liability, and modest reported operating cash flow due to deliberate inventory and payable timing. Management communicated a clear strategy to redeploy capital from Arizona to Ohio and to pay down debt, and they reported concrete near-term actions and improving trends.View all VEXTF earnings summariesTechnical Analysis
Leef Brands
―
Charlotte's Web Holdings
―
MediPharm Labs
―
Planet 13 Holdings
―
Avicanna
―